Literature DB >> 6130131

Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei.

M F Chesselet, T D Reisine.   

Abstract

The effects of somatostatin on the release of tritiated dopamine (DA) formed continuously from tritiated tyrosine were studied in vitro in superfused striatal slices and in vivo in both caudate nuclei and both substantiae nigrae of halothane-anesthetized cats using a push-pull cannula technique. Somatostatin (3 X 10(-10) to 3 X 10(-7) M) increased the spontaneous tritiated dopamine release from rat striatal slices. This effect was dose dependent and was completely prevented by tetrodotoxin (5 X 10(-7) M). When applied for 30 min in one cat caudate nucleus, somatostatin (10(-7) M) immediately increased the local release of tritiated DA, while a gradual inhibition of the tritiated amine's efflux was observed in the contralateral caudate nucleus. No changes in tritiated dopamine were seen in either substantia nigra during or after the peptide's application in the caudate nucleus. These results suggest that somatostatin in the striatum may play a role in the local and the distal control of dopamine release from the terminals of dopaminergic nigrostriatal neurons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130131      PMCID: PMC6564584     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  25 in total

1.  Relative expression of mRNA for the somatostatin receptors in the caudate putamen of C57BL/6J and 129P3/J mice: strain and heroin effects.

Authors:  Stefan D Schlussman; Jared Cassin; Orna Levran; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2010-05-15       Impact factor: 3.252

Review 2.  Somatostatin.

Authors:  T Reisine
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

3.  Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors.

Authors:  S Boehm; H Betz
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

4.  Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons.

Authors:  H L Wang; C Bogen; T Reisine; M Dichter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Frequency-dependent, cell type-divergent signaling in the hippocamposeptal projection.

Authors:  Joanna Mattis; Julia Brill; Suzanne Evans; Talia N Lerner; Thomas J Davidson; Minsuk Hyun; Charu Ramakrishnan; Karl Deisseroth; John R Huguenard
Journal:  J Neurosci       Date:  2014-08-27       Impact factor: 6.167

6.  Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.

Authors:  M Strittmatter; G F Hamann; D Strubel; H Cramer; K Schimrigk
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors.

Authors:  Elif Engin; Dallas Treit
Journal:  Psychopharmacology (Berl)       Date:  2009-07-17       Impact factor: 4.530

8.  Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy.

Authors:  S J Kish; Y Robitaille; M el-Awar; L Schut; L DiStefano; M J Ball; M F Mazurek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

9.  Functional in vivo interaction between growth hormone and dopamine systems are correlated to changes in striatal somatostatin levels as detected by voltammetry.

Authors:  F Crespi
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Effects of acute and chronic desipramine treatment on somatostatin receptors in brain.

Authors:  E G Gheorvassaki; K Thermos; G Liapakis; C Spyraki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.